Notes to SEFA
Title: Note 4: Provider Relief Funds
Accounting Policies: Note 1: Basis of Presentation - The accompanying consolidated schedule of expenditures of federal awards (the schedule) includes the federal award activity of the Agency under the programs of the federal government for the year ended June 30, 2022. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the schedule presents only a selected portion of the operations of the Agency, it is not intended to and does not present the financial position, changes in net assets, or cash flows of the Agency. Note 2: Summary of Significant Accounting Policies - Expenditures reported on the schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. No federal financial assistance has been provided to a subrecipient.
De Minimis Rate Used: N
Rate Explanation: The Agency has not elected to use the 10-percent de minimis indirect cost rate as allowed under the Uniform Guidance.
The Agency received $104,152 from the U.S. Department of Health and Human Services (HHS) through the Provider Relief Fund (PRF) program (Federal Financial Assistance Listing/CFDA #93.498). The Agency incurred eligible expenditures and, therefore, recognized revenue totaling $69,272 and $33,058 for the years ended June 30, 2022 and 2021, respectively, on the financial statements. In accordance with the OMB Compliance Supplement, the PRF expenditures recognized on the schedule are based on the reporting to HHS for the reporting periods during the year ended June 30, 2022, as required under the PRF program. The amount of PRF expenditures included on the schedule requires management to make estimates and assumptions that affect the reported amounts. Accordingly, such expenditures are considered a signification estimate. Estimates and assumptions may include reducing actual expenses by amounts that have been reimbursed or are obligated to be reimbursed by other sources, estimating marginal increases in expenses related to coronavirus. Actual results could differ from those estimates.